Form 4: HealthStream Executive Vice President Michael Collier Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
Executive Vice President Michael Collier of HealthStream Inc. reports the acquisition and disposal of company stock following the vesting of restricted share units (RSUs).
Summary
- On March 25, 2024, Michael Manning Collier, Executive Vice President of HealthStream Inc., reported transactions involving the company's common stock.
- These transactions include the acquisition of 9,363 shares upon the vesting of restricted share units (RSUs).
- Additionally, 2,280 shares were withheld for payment of tax liability at a price of $26.43.
- The reported transactions resulted in a change in Mr. Collier's direct ownership of HealthStream common stock, with the total holdings decreasing from 42,284 to 40,004 shares.
- The vesting of RSUs is subject to continued service and, in some cases, the achievement of certain performance criteria.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects routine executive compensation activity. The vesting of RSUs is a positive sign, but the tax-related share disposal is a neutral event.
Positives
- The vesting of RSUs indicates that performance or service conditions were met, which could be seen as a positive sign.
Negatives
- The disposal of 2,280 shares to cover tax liabilities, while a normal occurrence, represents a reduction in Mr. Collier's holdings.
Risks
- Future vesting of RSUs is contingent upon continued service and the achievement of performance criteria, which introduces uncertainty.
Future Outlook
Future vesting of RSUs depends on continued service and potentially the achievement of performance criteria set by the Compensation Committee.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's confidence in the company's future prospects.
Comparison to Industry Standards
- Executive compensation packages often include RSUs as a way to align management's interests with those of shareholders.
- Vesting schedules and performance criteria are typical components of RSU agreements in the healthcare technology industry.
- Companies like Cerner (now Oracle Health) and Allscripts also utilize RSUs as part of their executive compensation plans.
Stakeholder Impact
- The vesting of RSUs aligns executive compensation with company performance, potentially benefiting shareholders.
- The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/11/2021 | 15% of certain RSUs vested |
| 01/01/2022 | Start date for performance period related to some RSUs |
| 03/17/2022 | 15% of certain RSUs vested |
| 01/01/2023 | Start date for performance period related to some RSUs |
| 03/23/2023 | 15% of certain RSUs vested |
| 03/25/2024 | Date of reported transactions: RSU vesting and tax liability share withholding |
| 03/17/2023 | 20% of certain RSUs vested |
| 03/11/2024 | 35% of certain RSUs vested |
| 03/22/2024 | 15% of certain RSUs vested |
| 03/23/2024 | 20% of certain RSUs vested |
| 03/17/2024 | 30% of certain RSUs vested |
| 03/23/2025 | 30% of certain RSUs vest |
| 03/22/2025 | 20% of certain RSUs vest |
| 03/17/2025 | 35% of certain RSUs vest |
| 03/23/2026 | 30% of certain RSUs vest |
| 03/22/2026 | 30% of certain RSUs vest |
| 03/23/2027 | 25% of certain RSUs vest |
| 03/22/2027 | 35% of certain RSUs vest |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.